Chemotherapy plus atezolizumab for a patient with small cell lung cancer undergoing haemodialysis: a case report and review of literature

Little is known about the safety of chemotherapy plus atezolizumab for patients with extensive‐stage small cell lung cancer (ES‐SCLC) undergoing haemodialysis (HD). An 80‐year‐old male received carboplatin [area under the concentration‐time curve (AUC) = 5 on day 1], etoposide (40 mg/m(2) on days 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Imaji, Mihoko, Fujimoto, Daichi, Kato, Mai, Tanaka, Masanori, Furuta, Katsuyuki, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991827/
https://www.ncbi.nlm.nih.gov/pubmed/33777399
http://dx.doi.org/10.1002/rcr2.741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991827/
https://www.ncbi.nlm.nih.gov/pubmed/33777399
http://dx.doi.org/10.1002/rcr2.741

Ejemplares similares